ACTIVE

MUNDIPHARMA PHARMACEUTICALS BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
3,2 k €
-9,2 %over 1 year
Gross margin
4,8 k €
Equity
50,1 k €
+6,8 %over 1 year
Workforce
0,0 ETP

Identity

Source · BCE/KBO

MUNDIPHARMA PHARMACEUTICALS BELGIUM is a Private limited company incorporated in 2002. Its main activity is: Activities of holding companies. Its registered office is in Machelen (Brab.).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0478.189.412
Incorporation
14/08/2002
Legal form
Private limited company
Registered office
De Kleetlaan 4
1831 Machelen (Brab.) · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin4,8 k €––––
EBITDA4,4 k €4,6 k €7,2 k €5,1 k €6 k €
Operating result4,4 k €4,6 k €7,2 k €5,1 k €6 k €
Net result3,2 k €3,5 k €5 k €-4 €5,7 k €
Balance sheet
Equity50,1 k €47 k €43,5 k €38,4 k €38,4 k €
Total assets65,1 k €59,2 k €53,2 k €47,3 k €42,2 k €
Cash41 k €41,1 k €41,1 k €11,2 k €11,8 k €
Debts15 k €12,2 k €9,7 k €8,8 k €3,8 k €
Other
Workforce0,0 ETP––––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 9 ended

Active mandates

Adam GOODSELL

Director

Active
Stephen JAMIESON

Director

Active

Ended mandates

Ake Wikstrom

Manager · since 31 mars 2018

Ended
Christopher B. Mitchell

Manager

Ended
Floris Bongenaar

Mandate

Ended
Floris Bongenaar

Director

Ended

Other companies at this address

De Kleetlaan 4 1831 Machelen (Brab.)
CompanyCBE no.
4L & CIE● Active
1012.802.140
ACCOUNTANCY C & S● Bankrupt
0826.870.956
AG RIDE● Active
1019.379.235
AMARO GROUP● Active
1000.844.119
Baumann Concept● Bankrupt
0738.821.383
BELGODEV● Active
1026.460.235
BetterPlaceBetterLife● Bankrupt
0643.465.732
EASYMOOV● Active
1017.993.125
EASY Noise Control Belgium● Active
0764.537.667
EC ENERGY● Active
1008.867.997
FC-FOOD● Bankrupt
1009.483.552
FMG SOLUTIONS● Bankrupt
0738.976.187
Golden Azimuth● Active
0799.752.726
Ikaros Consulting● Active
0800.946.915
K LUANG● Active
0792.810.197
LEVONA GROUP● Bankrupt
0784.991.405
MAJOR PILLAR● Bankrupt
0790.900.287
MANAGEMENT & CONSULTING ORGANISATION● Bankrupt
0534.386.658
MUNDIPHARMA● Active
0479.294.321
OPTIMAL SERVICES AND MANAGEMENT● Bankrupt
0791.915.126

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date04/08/202630/07/202526/07/202429/09/202303/09/202202/09/2022
General meeting30/06/202630/06/202530/06/202422/09/202331/08/202224/08/2022
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202604/08/2026DutchPDF
Full model31/12/202430/06/202530/07/2025DutchPDF
Full model31/12/202330/06/202426/07/2024DutchPDF
Full model31/12/202222/09/202329/09/2023DutchPDF
Full model31/12/202131/08/202203/09/2022DutchPDF
Full model31/12/202024/08/202202/09/2022DutchPDF
Full model31/12/201930/03/202003/09/2022DutchPDF
Full model31/12/201806/05/201922/05/2019DutchPDF
Full model31/12/201707/05/201825/05/2018DutchPDF
Full model31/12/201602/05/201718/05/2017DutchPDF
Full model31/12/201530/05/201605/07/2016DutchPDF
Full model31/12/201404/05/201523/07/2015DutchPDF
Full model31/12/201305/05/201403/06/2014DutchPDF
Full model31/12/201206/05/201306/06/2013DutchPDF
Abridged model31/12/201107/05/201205/06/2012DutchPDF
Abridged model31/12/201002/05/201131/05/2011DutchPDF
Abridged model31/12/200903/05/201003/06/2010DutchPDF
Abridged model31/12/200804/05/200904/06/2009DutchPDF
Abridged model31/12/200705/05/200812/06/2008DutchPDF
Abridged model31/12/200607/05/200714/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 9 ended

Active mandates

Adam GOODSELL

Director

Active
Stephen JAMIESON

Director

Active

Ended mandates

Ake Wikstrom

Manager · since 31 mars 2018

Ended
Christopher B. Mitchell

Manager

Ended
Floris Bongenaar

Mandate

Ended
Floris Bongenaar

Director

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates11/09/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office13/02/2023
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates23/06/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/10/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/05/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/05/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/04/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20253,2 k €↓
  2. 2024
    Annual accounts 20243,5 k €↓
  3. 2023
    Annual accounts 20235 k €↑
  4. 2023
    Name changeMundipharma Pharmaceuticals
  5. 2022
    Annual accounts 2022-4 €↓
  6. 2022
    Name changeMundpharma Pharmaceuticals Belgium
  7. 2021
    Annual accounts 20215,7 k €↑
  8. 2020
    Annual accounts 20205,7 k €↑
  9. 2019
    Annual accounts 20192,3 k €↑
  10. 2019
    Name changeMundipharma Pharmaceuticals Belgium
  11. 2017
    Annual accounts 20171,6 k €↑
  12. 2016
    Annual accounts 20161,3 k €↑
  13. 2015
    Annual accounts 2015286,3 €↓
  14. 2014
    Annual accounts 20141,6 k €↑
  15. 2013
    Annual accounts 2013-725,7 €↓
  16. 2012
    Annual accounts 2012-364 €↓
  17. 2011
    Annual accounts 2011147 €↓
  18. 2010
    Annual accounts 2010960 €↓
  19. 2009
    Annual accounts 20094,1 k €↓
  20. 2008
    Annual accounts 20087,8 k €↑
  21. 2007
    Annual accounts 20076,6 k €↑
  22. 2006
    Annual accounts 2006-367 €
  23. 14/08/2002
    IncorporationPrivate limited company